[article] 
inJournal of Autism and Developmental Disorders > 42-8 (August 2012) . - p.1592-1605

Titre :	Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice
Type de document :	Texte imprimé et/ou numérique
Auteurs :	Matthew SIEGEL, Auteur ; Amy A. BEAULIEU, Auteur
Année de publication :	2012
Article en page(s) :	p.1592-1605
Langues :	Anglais (eng)
Mots-clés :	Autism  Evidence base  Pharmacology  Review  Trials
Index. décimale :	PER Périodiques
Résumé :	This paper presents a systematic review, rating and synthesis of the empirical evidence for the use of psychotropic medications in children with autism spectrum disorders (ASD). Thirty-three randomized controlled trials (RCTs) published in peer-reviewed journals qualified for inclusion and were coded and analyzed using a systematic evaluative method specific to autism research (Reichow et al. in Journal of Autism and Developmental Disorders 38:1311–1319, 2008). Results are presented by agent and primary target symptom(s). The findings suggest established evidence for relatively few agents, with preliminary and promising evidence for a larger group. Challenges and opportunities in the developing field of ASD psychopharmacology are identified, and recommendations for further research are provided.
En ligne :	http://dx.doi.org/10.1007/s10803-011-1399-2
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=178

[article] Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice [Texte imprimé et/ou numérique] / Matthew SIEGEL, Auteur ; Amy A. BEAULIEU, Auteur . - 2012 . - p.1592-1605.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 42-8 (August 2012) . - p.1592-1605

Mots-clés :	Autism  Evidence base  Pharmacology  Review  Trials
Index. décimale :	PER Périodiques
Résumé :	This paper presents a systematic review, rating and synthesis of the empirical evidence for the use of psychotropic medications in children with autism spectrum disorders (ASD). Thirty-three randomized controlled trials (RCTs) published in peer-reviewed journals qualified for inclusion and were coded and analyzed using a systematic evaluative method specific to autism research (Reichow et al. in Journal of Autism and Developmental Disorders 38:1311–1319, 2008). Results are presented by agent and primary target symptom(s). The findings suggest established evidence for relatively few agents, with preliminary and promising evidence for a larger group. Challenges and opportunities in the developing field of ASD psychopharmacology are identified, and recommendations for further research are provided.
En ligne :	http://dx.doi.org/10.1007/s10803-011-1399-2
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=178